Researchers from the Hebrew University of Jerusalem, Israel’s Weizmann Institute and the University of Tokyo have created the peptide D’20 that targets and inhibits an enzyme called Matrix Metallopeptidase 7 (MMP7). MMP7 helps cancer cells invade surrounding tissues.
Cancer therapy targets a “bad” enzyme
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.